Search

Search Results

• 

  Pre-clinical anticancer drugs screening: perspectives from emerging models of glioma biology

  Juan Sebastian Yakisich

  e1

  28-12-2010

  https://doi.org/10.4081/dts.2011.e1

  895

  PDF: 584

  HTML: 324
• 

  Challenges and limitations of targeting cancer stem cells and/or the tumour microenvironment

  Juan Sebastian Yakisich

  e10

  10-05-2012

  https://doi.org/10.4081/dts.2012.e10

  4892

  PDF: 1270
• 

  Intracellular delivery of NF-κB small interfering RNA for modulating therapeutic activities of classical anti-cancer drugs in human cervical cancer cells

  Anthony Stanislaus, Anil Philip Kunnath, Snigdha Tiash, Tahereh Fatemian, Nur Izyani Kamaruzman, Athirah Bakhtiar, Sayyad Mustak, Sharif Hossain, Toshihiro Akaike, Ezharul Hoque Chowdhury

  e7

  10-12-2013

  https://doi.org/10.4081/dts.2013.e7

  3717

  PDF: 793
• 

  Antimetastatic therapy targeting aberrant sialylation profiles in cancer cells

  Da Yong Lu, Ting Ren Lu, Hong-Ying Wu

  e12

  08-09-2011

  https://doi.org/10.4081/dts.2011.e12

  1480

  PDF: 703
• 

  Dendritic cell dysfunction and implications for dendritic cell-based therapy in colorectal cancer

  Michael Vallop Josiassen, Kajsa Paulsson

  e14

  02-11-2011

  https://doi.org/10.4081/dts.2011.e14

  968

  PDF: 704
• 

  C11 cyclopentenone from the ascidian Diplosoma sp. prevents epidermal growth factor-induced transformation of JB6 cells

  Sergey N. Fedorov, Sergey A. Dyshlovoy, Larisa K. Shubina, Alla Guzii, Alexandra S. Kuzmich, Tatyana N. Makarieva

  e4

  30-01-2012

  https://doi.org/10.4081/dts.2012.e4

  2497

  PDF: 680
• 

  Fabrication and intracellular delivery of siRNA/carbonate apatite nano-composites for effective knockdown of cyclin B1 gene

  Anthony Stanislaus, Sharif Hossain, Ming Jang Chua, Anil Philip Kunnath, Quek Chia Wen, Sharifah Nur Syakira, Gan Yew Siong, Siong Wei Loong, Iekhsan Othman, Toshihiro Akaike, Ezharul Hoque Chowdhury

  e8

  08-07-2011

  https://doi.org/10.4081/dts.2011.e8

  2305

  PDF: 1384
• 

  Bevacizumab and etoposide combination chemotherapy in patients with recurrent malignant gliomas who failed bevacizumab

  Beverly D. Fu, Mark E. Linskey, Daniela Annenelie Bota

  e6

  24-02-2012

  https://doi.org/10.4081/dts.2012.e6

  1508

  PDF: 728
• 

  Malodorous oozing lesions after local cancer treatment - ethacridine powder prevents local infection

  Gerhard Dyckhoff, Peter Karl Plinkert, Stefanie Ursula Walk-Fritz, Torsten Hoppe-Tichy

  e9

  09-08-2011

  https://doi.org/10.4081/dts.2011.e9

  1714

  PDF: 738
• 

  Depletion of drug-surviving glioma cells by a second phase treatment with low concentration of salinomycin

  Zahid M. Delwar, Dimitrios Avramidis, Åke Siden, Mabel Cruz, Juan Sebastian Yakisich

  e7

  15-06-2011

  https://doi.org/10.4081/dts.2011.e7

  1818

  PDF: 751

  Supplementary Table 1: 144
• 

  Effect of the neridronate on RANKL release in differentiated primary human osteoblasts

  Vanessa Nicolin, Roberto Valentini, Roberta Bortul, Giovanni Fancellu

  e3

  29-03-2011

  https://doi.org/10.4081/dts.2011.e3

  1027

  PDF: 592

  HTML: 1323